Corbus Pharmaceuticals Holdings IncNASDAQ:CRBP
- LAST PRICE52.8900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots52.0600/ 1
- Ask / Lots54.5500/ 1
- Open / Previous Close51.0700 / 52.8900
- Day Range
- 52 Week Range
- Volume301,528
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRBP |
|---|---|---|
| 09:32 ET | 2688 | 51.92 |
| 09:34 ET | 1700 | 51.575 |
| 09:36 ET | 1580 | 51.14 |
| 09:38 ET | 1200 | 51.22 |
| 09:39 ET | 742 | 51.15 |
| 09:41 ET | 1696 | 51.415 |
| 09:43 ET | 300 | 51.5 |
| 09:45 ET | 1036 | 51.38 |
| 09:50 ET | 3272 | 51.74 |
| 09:52 ET | 1967 | 51.95 |
| 09:54 ET | 1101 | 51.51 |
| 09:56 ET | 2501 | 52.06 |
| 09:57 ET | 1190 | 52.065 |
| 09:59 ET | 2400 | 52.3626 |
| 10:01 ET | 2002 | 52.71 |
| 10:03 ET | 400 | 53.16 |
| 10:06 ET | 500 | 53.4 |
| 10:08 ET | 200 | 53.31 |
| 10:10 ET | 1460 | 53.46 |
| 10:12 ET | 300 | 53.7 |
| 10:14 ET | 529 | 53.7795 |
| 10:15 ET | 1605 | 53.27 |
| 10:17 ET | 550 | 53.51 |
| 10:19 ET | 300 | 52.27 |
| 10:21 ET | 230 | 53.03 |
| 10:24 ET | 798 | 53.51 |
| 10:26 ET | 1650 | 54.12 |
| 10:28 ET | 400 | 53.315 |
| 10:30 ET | 200 | 53.86 |
| 10:32 ET | 6576 | 53.585 |
| 10:33 ET | 800 | 53.22 |
| 10:35 ET | 300 | 53.01 |
| 10:37 ET | 200 | 53.3 |
| 10:39 ET | 534 | 53.37 |
| 10:42 ET | 400 | 53.98 |
| 10:46 ET | 100 | 54.27 |
| 10:48 ET | 200 | 53.93 |
| 10:53 ET | 200 | 53.76 |
| 10:57 ET | 2479 | 53.91 |
| 11:00 ET | 200 | 53.94 |
| 11:02 ET | 450 | 54 |
| 11:04 ET | 200 | 53.725 |
| 11:06 ET | 200 | 53.405 |
| 11:08 ET | 200 | 53.55 |
| 11:09 ET | 300 | 53.77 |
| 11:11 ET | 100 | 53.59 |
| 11:13 ET | 100 | 53.52 |
| 11:15 ET | 100 | 53.37 |
| 11:18 ET | 100 | 53.54 |
| 11:22 ET | 400 | 53.46 |
| 11:24 ET | 1800 | 53.535 |
| 11:26 ET | 1400 | 54 |
| 11:27 ET | 313 | 54.01 |
| 11:29 ET | 900 | 54.085 |
| 11:31 ET | 700 | 53.755 |
| 11:33 ET | 120 | 54.212 |
| 11:36 ET | 100 | 54.38 |
| 11:38 ET | 200 | 53.79 |
| 11:40 ET | 241 | 53.9 |
| 11:42 ET | 200 | 53.97 |
| 11:45 ET | 400 | 53.845 |
| 11:47 ET | 709 | 53.955 |
| 11:51 ET | 500 | 53.98 |
| 11:54 ET | 200 | 53.955 |
| 11:56 ET | 200 | 53.72 |
| 12:00 ET | 619 | 53.82 |
| 12:02 ET | 566 | 53.4201 |
| 12:03 ET | 400 | 53.635 |
| 12:05 ET | 505 | 53.62 |
| 12:07 ET | 300 | 53.4 |
| 12:09 ET | 100 | 53.3675 |
| 12:12 ET | 100 | 53.41 |
| 12:18 ET | 5680 | 53.69 |
| 12:20 ET | 233 | 53.26 |
| 12:21 ET | 300 | 53.54 |
| 12:25 ET | 200 | 53.54 |
| 12:27 ET | 1955 | 52.84 |
| 12:30 ET | 800 | 52.93 |
| 12:32 ET | 1200 | 53.07 |
| 12:34 ET | 900 | 53.155 |
| 12:36 ET | 633 | 53.123 |
| 12:38 ET | 100 | 52.91 |
| 12:41 ET | 100 | 53.14 |
| 12:43 ET | 100 | 53.04 |
| 12:45 ET | 530 | 53 |
| 12:50 ET | 100 | 53.3399 |
| 12:52 ET | 300 | 53.365 |
| 12:54 ET | 665 | 53.345 |
| 12:56 ET | 100 | 53.56 |
| 01:01 ET | 300 | 53.455 |
| 01:03 ET | 223 | 53.515 |
| 01:06 ET | 500 | 53.86 |
| 01:08 ET | 100 | 53.71 |
| 01:10 ET | 700 | 54.095 |
| 01:12 ET | 3238 | 53.78 |
| 01:14 ET | 400 | 53.73 |
| 01:15 ET | 563 | 53.44 |
| 01:17 ET | 165 | 53.87 |
| 01:21 ET | 149 | 53.845 |
| 01:24 ET | 400 | 53.75 |
| 01:26 ET | 657 | 53.785 |
| 01:28 ET | 200 | 53.795 |
| 01:30 ET | 300 | 53.795 |
| 01:32 ET | 1099 | 53.65 |
| 01:33 ET | 263 | 53.7975 |
| 01:35 ET | 584 | 53.805 |
| 01:39 ET | 100 | 53.775 |
| 01:42 ET | 2367 | 53.96 |
| 01:44 ET | 200 | 54.0045 |
| 01:46 ET | 100 | 53.955 |
| 01:48 ET | 208 | 54.0325 |
| 01:50 ET | 100 | 53.925 |
| 01:51 ET | 364 | 53.93 |
| 01:53 ET | 827 | 53.965 |
| 01:57 ET | 100 | 53.81 |
| 02:00 ET | 301 | 54.1999 |
| 02:02 ET | 505 | 54.02 |
| 02:04 ET | 500 | 53.85 |
| 02:08 ET | 100 | 53.945 |
| 02:09 ET | 263 | 53.91 |
| 02:11 ET | 266 | 53.925 |
| 02:13 ET | 800 | 53.92 |
| 02:15 ET | 300 | 53.925 |
| 02:18 ET | 600 | 53.925 |
| 02:20 ET | 200 | 53.96 |
| 02:22 ET | 800 | 53.95 |
| 02:24 ET | 1065 | 53.945 |
| 02:26 ET | 642 | 53.86 |
| 02:27 ET | 200 | 53.8875 |
| 02:29 ET | 100 | 53.86 |
| 02:31 ET | 6143 | 53.86 |
| 02:36 ET | 100 | 53.855 |
| 02:38 ET | 1028 | 53.995 |
| 02:40 ET | 1844 | 54.03 |
| 02:42 ET | 1200 | 54.2 |
| 02:44 ET | 700 | 54.01 |
| 02:45 ET | 263 | 53.985 |
| 02:47 ET | 742 | 53.915 |
| 02:49 ET | 700 | 53.925 |
| 02:51 ET | 1791 | 53.77 |
| 02:54 ET | 500 | 53.765 |
| 02:56 ET | 300 | 53.57 |
| 02:58 ET | 366 | 53.735 |
| 03:00 ET | 700 | 53.735 |
| 03:02 ET | 1626 | 53.3 |
| 03:03 ET | 200 | 53.37 |
| 03:05 ET | 2376 | 53.255 |
| 03:07 ET | 1688 | 53.245 |
| 03:09 ET | 11176 | 53.435 |
| 03:12 ET | 363 | 53.43 |
| 03:14 ET | 685 | 53.495 |
| 03:16 ET | 205 | 53.505 |
| 03:18 ET | 100 | 53.46 |
| 03:20 ET | 300 | 53.4375 |
| 03:21 ET | 300 | 53.32 |
| 03:23 ET | 568 | 53.3 |
| 03:25 ET | 919 | 52.815 |
| 03:27 ET | 100 | 52.81 |
| 03:30 ET | 6432 | 53.08 |
| 03:32 ET | 469 | 53.065 |
| 03:36 ET | 1837 | 52.57 |
| 03:38 ET | 100 | 52.8325 |
| 03:41 ET | 260 | 52.81 |
| 03:43 ET | 303 | 52.7 |
| 03:45 ET | 605 | 52.81 |
| 03:48 ET | 400 | 52.825 |
| 03:50 ET | 2205 | 52.76 |
| 03:52 ET | 1050 | 52.64 |
| 03:54 ET | 505 | 52.8 |
| 03:56 ET | 2802 | 53.06 |
| 03:57 ET | 2069 | 52.785 |
| 03:59 ET | 15372 | 52.89 |
Jun 11, 2024
DJ Corbus Pharmaceuticals Is Maintained at Outperform by RBC Capital, from 8:27AM ET on Tuesday Jun 11, 2024 by Dow Jones
8:27AM ET on Tuesday Jun 11, 2024 by Dow Jones
Jun 3, 2024
DJ Corbus Pharmaceuticals Reaches 2-Year High After Drug Results, from 1:11PM ET on Monday Jun 03, 2024 by Dow Jones
1:11PM ET on Monday Jun 03, 2024 by Dow JonesDJ Corbus Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 8:33AM ET on Monday Jun 03, 2024 by Dow Jones
8:33AM ET on Monday Jun 03, 2024 by Dow Jones
Jun 1, 2024
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024, from 10:00AM ET on Saturday Jun 01, 2024 by Dow Jones
10:00AM ET on Saturday Jun 01, 2024 by Dow Jones
May 30, 2024
Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference, from 8:00AM ET on Thursday May 30, 2024 by Dow Jones
8:00AM ET on Thursday May 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 443.5M | -7.6x | --- |
Neurogene Inc | 441.7M | -9.2x | --- |
Annexon Inc | 437.1M | -4.1x | --- |
Larimar Therapeutics Inc | 453.0M | -10.0x | --- |
Terns Pharmaceuticals Inc | 454.0M | -6.3x | --- |
Nkarta Inc | 458.0M | -2.7x | --- |
Company Information
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Contact Information
- Headquarters
- 500 River Ridge DriveNORWOOD, MA, United States 02062
- Phone
- 617-963-0103
- Fax
- ---
Executives
- Independent Chairman of the Board
- Alan Holmer
- Chief Executive Officer, Director
- Yuval Cohen
- Chief Financial Officer
- Sean Moran
- Chief Medical Officer
- Dominic Smethurst
- Independent Director
- Anne Altmeyer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $547.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 10.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.61 |
EPS | $-6.97 |
Book Value | $-1.56 |
P/E Ratio | -7.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
